{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:34:19Z","timestamp":1781649259555,"version":"3.54.5"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Herpes reactivation is a rare complication in patients receiving immunosuppressive medications, particularly tumor necrosis factor (TNF) inhibitors, particularly when it manifests as myelitis. Meanwhile, a first episode of transverse myelitis is closely related to the early risk of developing a demyelinating disease such as multiple sclerosis (MS) and MS-like conditions. We report the case of a middle eastern man in his early 30s who was previously diagnosed with spondyloarthritis, currently treated with adalimumab, and who developed cervical myelitis, showing as a T2 hypersignal on magnetic resonance imaging (MRI) localized at the level of his C2 vertebra with a unilateral clinical presentation, concomitant with positive serology testing for herpes simplex virus (HSV), suggestive of a reactivation, in the absence of a feasible cerebrospinal fluid (CSF) analysis. Management was primarily through methylprednisolone pulse therapy and intravenous (IV) acyclovir, in addition to physical rehabilitation and the temporary discontinuation of adalimumab, yielding positive results and a full recovery at 6\u202fmonths. This case highlights the importance of early detection and treatment of neuroimmune complications in patients receiving immunosuppressive therapy, using non-invasive and minimally invasive techniques. It also showcases the complexity of differentials for acute transverse myelitis when no sufficient evidence is available for a neuroinfectious or demyelinating disease diagnosis.<\/jats:p>","DOI":"10.3389\/fmed.2026.1787999","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:52:38Z","timestamp":1778219558000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Suspected HSV vs. demyelinating transverse myelitis in patient on TNF alpha inhibitor: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Sarah","family":"Mahfouz","sequence":"first","affiliation":[{"name":"School of Medicine and Medical Sciences, Holy Spirit University of Kaslik","place":["Byblos, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Loutfi","sequence":"additional","affiliation":[{"name":"School of Medicine and Medical Sciences, Holy Spirit University of Kaslik","place":["Byblos, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Jreige","sequence":"additional","affiliation":[{"name":"School of Medicine and Medical Sciences, Holy Spirit University of Kaslik","place":["Byblos, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Mattar","sequence":"additional","affiliation":[{"name":"School of Medicine and Medical Sciences, Holy Spirit University of Kaslik","place":["Byblos, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"32768","DOI":"10.1038\/srep32768","article-title":"Efficacy and safety of TNF-\u03b1 inhibitors for active ankylosing spondylitis patients: multiple treatment comparisons in a network meta-analysis","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jbspin.2013.07.009","article-title":"Risk of herpes\/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis","volume":"81","author":"Che","year":"2014","journal-title":"Joint Bone Spine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti\u2013TNF-\u03b1 agents","volume":"301","author":"Strangfeld","year":"2009","journal-title":"JAMA"},{"key":"ref4","volume-title":"StatPearls","author":"Simone","year":"2026"},{"key":"ref5","volume-title":"Transverse Myelitis | National Institute of Neurological Disorders and Stroke","year":""},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1210972","DOI":"10.3389\/fneur.2023.1210972","article-title":"Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"14","author":"Perez-Giraldo","year":"2023","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pedneo.2015.11.001","article-title":"Herpes simplex virus-related transverse myelitis and polyneuritis","volume":"57","author":"Ding","year":"2016","journal-title":"Pediatr Neonatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fneur.2017.00199","article-title":"Herpes simplex virus type 2 myelitis: case report and review of the literature","volume":"8","author":"Nardone","year":"2017","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijid.2020.11.134","article-title":"Herpes simplex virus type 2 myelitis mimicking ICU-acquired weakness as a complication of meningococcal meningitis: a case report","volume":"103","author":"Tsutsumi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jns.2017.01.023","article-title":"TNF-alpha inhibitor associated myelopathies: a neurological complication in patients with rheumatologic disorders","volume":"373","author":"Barreras","year":"2017","journal-title":"J Neurol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2515\/therapie\/2014031","article-title":"My\u00e9lite sous anti-TNF\u03b1: y penser, meme tardivement","volume":"69","author":"St\u00e8ve-Dumont","year":"2014","journal-title":"Therapies"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e04878","DOI":"10.1002\/ccr3.4878","article-title":"Acute transverse myelitis revealing ankylosing spondylitis: a case report and literature review","volume":"9","author":"Boussaid","year":"2021","journal-title":"Clin Case Reports"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref14","first-page":"31","article-title":"Herpes simplex virus infections: an overview of testing for the urgent care clinician","volume":"19","author":"Tice","year":"2025","journal-title":"JUCM J Urgent Care Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1212\/WNL.0000000000201629","article-title":"Tumor necrosis factor \u03b1 blockers and the risk of multiple sclerosis","volume":"100","author":"Strijbis","year":"2023","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e200460","DOI":"10.1212\/NXI.0000000000200460","article-title":"Epstein-Barr virus in multiple sclerosis","volume":"12","author":"Wahbeh","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1787999\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:52:40Z","timestamp":1778219560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1787999\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":17,"alternative-id":["10.3389\/fmed.2026.1787999"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1787999","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1787999"}}